NTSAD to honor Guangping Gao for lifetime work on Canavan disease, as gene therapy trial shows promise

Guangping Gao, PhD, will be honored by the National Tay-Sachs & Allied Diseases Association for his work in identifying the Canavan gene, revitalizing gene therapy, and his many accomplishments leading to potential treatments for Canavan disease.

Related Keywords

United States ,Boston ,Massachusetts ,Bio Pharma ,Florian Eichler ,Guangping Gao ,Drug Administration ,Harvard Medical School ,Hospital Center ,Penelope Booth Rockwell Professor In Biomedical Research ,National Tay Sachs Allied Diseases Association ,European Union ,Li Weibo Institute For Rare Diseases Research ,Horae Gene Therapy Center ,National Tay Sachs ,Allied Diseases Association ,Penelope Booth Rockwell Professor ,Biomedical Research ,Rare Diseases Research ,Bridgebio Pharma ,Child Neurology Society ,Gene Therapy Trial ,Canavan Disease ,Massachusetts General Hospital ,Rare Neurological Diseases ,